Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$947,572
-$144,459 QoQ
Shares Held
39,351
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,354
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROBERTS GLORE & CO INC /IL/ holds $30,036,472 across 10 Drug Manufacturers - General names. PFE ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,900 | $12,673,103 | |
| 2 | ABBV |
AbbVie Inc.
|
29,453 | $7,411,552 | |
| 3 | AMGN |
Amgen Inc
|
6,771 | $2,451,914 | |
| 4 | NVS |
Novartis AG
|
12,498 | $1,958,686 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
9,885 | $1,248,870 | |
| 6 | NVO |
Novo Nordisk A S
|
25,727 | $1,233,352 | |
| 7 | PFE |
Pfizer Inc
This page
|
39,351 | $947,572 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,037 | $775,754 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $947,572 | 39,351 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,092,031 | 38,890 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,062,109 | 42,655 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,017,722 | 39,942 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $937,118 | 38,660 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,086,477 | 42,876 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,087,544 | 40,993 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,138,615 | 39,344 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,105,937 | 39,526 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $907,508 | 32,703 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $788,385 | 27,384 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $439,469 | 13,249 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $459,930 | 12,539 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $509,755 | 12,494 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $607,296 | 11,852 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $516,455 | 11,802 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $624,021 | 11,902 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $621,343 | 12,002 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $783,475 | 13,268 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $572,893 | 13,320 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $640,266 | 16,350 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $618,156 | 17,062 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $583,880 | 15,862 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $587,639 | 16,012 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $525,227 | 16,062 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $528,669 | 16,197 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||